Retinal Surgery Devices Market To Reach $4.76 Billion By 2030

Retinal Surgery Devices Market Growth & Trends

The global retinal surgery devices market size is estimated to reach USD 4.76 billion by 2030, expanding at a CAGR of 9.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. The unprecedented growth is presumed to be a consequence of the growing prevalence of retinal eye disorders such as retinal detachment, macular degeneration, amblyopia, and others. Rising patient preference for minimally invasive surgeries is believed to be one of the major growth of contributory factors. The increasing demand is predicted to be a result of associated benefits such as improved cost-efficiency, safety, rapid recovery, efficacy, and reduced hospital stay. Other advantages include fewer incision wounds and reduced postsurgical complications that lead to higher patient satisfaction.

The market is also driven by technological upgradations that are responsible for the heightened inclination of physicians, thereby, widening the scope for greater adoption of retinal surgery devices in the future. The technologically advanced devices are equipped with fundus imaging units, micro-incision technology, endoillumination systems. These advancements are primarily witnessed in surgical instrumentation to facilitate easy & safe operative procedures. For instance, the launch of VersaVIT 2.0 vitrectomy machine is equipped with an LED illumination system, 3 vitrectomy packs, and adjustable chandelier fiber. Similarly, 23-Gauge fragmentation needle eliminates the need to enlarge sclerotomy and achieve enhanced visualization, intraoperative efficiency, and control.

 Request a free sample copy or view report summary: Retinal Surgery Devices Market Report

Retinal Surgery Devices Market Report Highlights

• Retinal laser equipment is predicted to observe exponential growth owing to consistency in the usage of a wide range of retinal operative procedures, high cost-efficiency, availability, and easy operability of the products

• The diabetic retinopathy segment accounted for the largest revenue share of 30.1% in 2024 as a consequence of high prevalence, raising the clinical urgency to adopt retinal surgery devices, thereby, fueling their penetration scope over the coming years

• Hospitals held the largest share in the end-use segment due to high patient volume, consistent readmissions, and easy availability of high-end equipment

• North America accounted for the largest share, which can be attributed to the extensive R&D activities that are likely to provide a platform for growth through consistent new product approvals

• The market in Asia Pacific is projected to witness substantial growth over the next decade, due to growing awareness pertaining to availability and benefits of these devices, further triggering significant penetration

• The competition is marked by companies indulging in a number of mergers & acquisitions, distribution agreements, and product approvals leading to significant growth

• For instance, In July 2024, Alcon Inc. announced the acquisition of Belkin Vision. It aims to expand the Glaucoma portfolio with direct selective laser trabeculoplasty (SLT). As it identified that SLT is cost effective and clinically relevant treatment for open angle glaucoma and ocular hypertension.

Retinal Surgery Devices Market Segmentation

Grand View Research has segmented the global retinal surgery devices market based on product, application, end use and region:

Retinal Surgery Devices Product Outlook (Revenue, USD Million, 2018 - 2030)

• Vitrectomy Machines

• Vitrectomy Packs

• Surgical Instruments

• Microscopic Illumination Equipment

• Retinal Laser Equipment

• Others

Retinal Surgery Devices Application Outlook (Revenue, USD Million, 2018 - 2030)

• Clinical

• Diabetic Retinopathy

• Retinal Detachment

• Epiretinal Membrane

• Macular Hole

• Others

Retinal Surgery Devices End-Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Eye Clinics

• Others

Retinal Surgery Devices Regional Outlook (Revenue, USD Million; 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Retinal Surgery Devices Market

• Alcon Inc.

• Carl Zeiss Meditec AG

• Bausch + Lomb

• TOPCON CORPORATION

• IRIDEX Corporation

• Escalon Medical Corp

• Lumenis Be Ltd.

• NIDEK CO., LTD.